Skip to main content
. 2020 Jun 29;9(1):1785161. doi: 10.1080/20013078.2020.1785161

Table 1.

Clinical applications of exosomes in drug delivery and regenerative medicine.

  Drug delivery Regenerative medicine
Definitions In which exosomal cargo is modified to contain a specific compound, including but not limited to a particular protein, miRNA, or pharmaceutical drug, for treatment In which exosomes are used as naturally produced for treatment
Number of Papers 360 338
Number of Clinical Trials 2 13
Pros Highly specific organotropic behaviour [6,15]
Biocompatible [6]
Can be engineered to increase drug load or improve stability and targeting ability [6,12,15]
Stable during cryopreservation [16]
Naturally crosses cell membranes and the BBB [30,54]
Avoid macrophage uptake, resulting in long blood circulation [54]
Large surface area to volume ratio allows exosomes to carry a significant amount of surface cargo [4]
Can carry hydrophobic and hydrophilic drugs [15]
Highly specific organotrophic behaviour [40,48,54, B. 18,26]
Nonimmunogenic [54]
Can be selected to carry specific proteins, receptors, or nucleic acids for gene therapy via cell culture microenvironment [9,16,35,64, B. 26]
Stable during cryopreservation [16]
Naturally crosses cell membranes and the BBB [63]
Regulate tissue homoeostasis [36,54]
Initiates tissue repair and regeneration [2,17,34,36,40,48]
Released by most cell types, enabling tissue-specific signalling [48,54]
Long-lasting paracrine effects [39,40]
Cons Difficult to produce enough yield to be effective in humans [6]
All isolation techniques have cons, including time, monetary cost, forming aggregates, introducing contaminants [6,54]
Systemic administration has not reflected targeting potential [6]
Difficult to produce enough yield to be effective in humans [10,64]
All isolation techniques have cons, including time, monetary cost, forming aggregates, introducing contaminants [16,63,66]
No single way to manufacture exosomes of a specific potency [10,16]
Representative Companies Anjarium Biosciences
ArunA Biomedical
Codiak Biosciences
Evox Therapeutics
Exogenus Therapeutics
Aegle Therapeutics
BreStem Therapeutics
Capricor Therapeutics
Kimera Exosomes
ReNeuron
Tavec Pharma
Xollent Biotech